首页 > 最新文献

Gastroenterology Research and Practice最新文献

英文 中文
Application of Antithrombotic Drugs in Different Age-Group Patients with Upper Gastrointestinal Bleeding 抗血栓药物在不同年龄段上消化道出血患者中的应用
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-04-04 DOI: 10.1155/2024/1710708
Ding Peng, Huihong Zhai
Objective. This study aimed at exploring the safety and timing of antithrombotic drugs in different age-group patients with UGIB. Methods. An observational study retrospectively based on the single-center database with 713 patients with UGIB. Result. Among the 713 patients, 62.13% were elderly patients ( years) and the mortality was 2.9%. In elderly patients with UGIB, we found that previous medication history, resumption of medication, and time of resumption did not affect the in-hospital mortality. The resumption of anticoagulants increased the risk of rebleeding. The independent risk factors of mortality were CHF, cirrhosis, creatine kinase, and albumin. The independent risk factors of rebleeding were the application of anticoagulants during hospitalization, variceal bleeding, black stool, red blood cells (lab), platelets (lab), and heart rate. Conclusions. In UGIB patients, a history of antiplatelet or antithrombotic drugs and the use of antiplatelet drugs after UGIB did not affect the patient’s prognosis. In elderly UGIB patients, although antithrombotic drugs did not increase the risk of death, the increased risk of rebleeding after resumption of use deserved careful treatment. It was safe to recover anticoagulant drugs as soon as possible in young UGIB patients.
研究目的本研究旨在探讨不同年龄组 UGIB 患者使用抗血栓药物的安全性和时机。方法基于单中心数据库对 713 例 UGIB 患者进行回顾性观察研究。结果在 713 例患者中,62.13% 为老年患者(岁),死亡率为 2.9%。在老年 UGIB 患者中,我们发现既往用药史、恢复用药和恢复用药的时间并不影响院内死亡率。抗凝药物的恢复会增加再出血的风险。死亡率的独立风险因素是心房颤动、肝硬化、肌酸激酶和白蛋白。再出血的独立危险因素是住院期间应用抗凝剂、静脉曲张出血、黑便、红细胞(实验室)、血小板(实验室)和心率。结论在 UGIB 患者中,抗血小板或抗血栓药物史以及 UGIB 后使用抗血小板药物不会影响患者的预后。在老年 UGIB 患者中,虽然抗血栓药物不会增加死亡风险,但恢复使用后再出血的风险增加,值得谨慎治疗。对于年轻的 UGIB 患者,尽快恢复使用抗凝药物是安全的。
{"title":"Application of Antithrombotic Drugs in Different Age-Group Patients with Upper Gastrointestinal Bleeding","authors":"Ding Peng, Huihong Zhai","doi":"10.1155/2024/1710708","DOIUrl":"https://doi.org/10.1155/2024/1710708","url":null,"abstract":"<i>Objective</i>. This study aimed at exploring the safety and timing of antithrombotic drugs in different age-group patients with UGIB. <i>Methods</i>. An observational study retrospectively based on the single-center database with 713 patients with UGIB. <i>Result</i>. Among the 713 patients, 62.13% were elderly patients (<span><svg height=\"12.7112pt\" style=\"vertical-align:-3.403299pt\" version=\"1.1\" viewbox=\"-0.0498162 -9.3079 35.429 12.7112\" width=\"35.429pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"></path></g><g transform=\"matrix(.013,0,0,-0.013,5.642,0)\"></path></g><g transform=\"matrix(.013,0,0,-0.013,11.621,0)\"></path></g><g transform=\"matrix(.013,0,0,-0.013,17.212,0)\"></path></g><g transform=\"matrix(.013,0,0,-0.013,27.798,0)\"></path></g></svg><span></span><svg height=\"12.7112pt\" style=\"vertical-align:-3.403299pt\" version=\"1.1\" viewbox=\"39.0111838 -9.3079 12.655 12.7112\" width=\"12.655pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,39.061,0)\"></path></g><g transform=\"matrix(.013,0,0,-0.013,45.301,0)\"></path></g></svg></span> years) and the mortality was 2.9%. In elderly patients with UGIB, we found that previous medication history, resumption of medication, and time of resumption did not affect the in-hospital mortality. The resumption of anticoagulants increased the risk of rebleeding. The independent risk factors of mortality were CHF, cirrhosis, creatine kinase, and albumin. The independent risk factors of rebleeding were the application of anticoagulants during hospitalization, variceal bleeding, black stool, red blood cells (lab), platelets (lab), and heart rate. <i>Conclusions</i>. In UGIB patients, a history of antiplatelet or antithrombotic drugs and the use of antiplatelet drugs after UGIB did not affect the patient’s prognosis. In elderly UGIB patients, although antithrombotic drugs did not increase the risk of death, the increased risk of rebleeding after resumption of use deserved careful treatment. It was safe to recover anticoagulant drugs as soon as possible in young UGIB patients.","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"49 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140587373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Death in Patients with Severe Acute Pancreatitis in Guizhou Province, China 中国贵州省重症急性胰腺炎患者死亡的风险因素
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-04-01 DOI: 10.1155/2024/8236616
Jun Li, Jingyan Gao, Min Huang, Xiaoyun Fu, Bao Fu
Aim. To compare the clinical characteristics of survival and nonsurvival patients with severe acute pancreatitis (SAP) and explore the risk of mortality in SAP patients. Methods. This was a single-center retrospective study performed in a severe acute pancreatitis diagnosis and treatment center. According to the outcome, SAP patients were divided into survival group and nonsurvival group. One-way ANOVA or independent -test was used to compare the clinical characteristics of two groups of patients. Multivariate retrospective analysis was used to identify risk factors for mortality in SAP patients. Results. A total of 486 SAP patients were included in the study, and the 90-day mortality for SAP patients was 13.58%. The common etiologies of SAP are biliary tract diseases (69.75%) and hyperlipidemia (17.28%). The most common complications caused by SAP were organ failure (55.14%), ARDS (50.62%), AKI (30.45%), sepsis (27.16%), and abdominal fluid collection (27.57%). There were differences in age, complications, and medical intervention between the nonsurvival group and the survival group. The main causes of death were infection (46.97%), abdominal bleeding (28.79%), and organ failure (9.09%). The binary logistic regression analysis showed that there were significant differences in age, AKI, sepsis, abdominal hemorrhage, organ failure, laparotomy, creatinine, and APTT between the nonsurvival group and the survival group. Conclusion. Age, AKI, sepsis, abdominal hemorrhage, and organ failure are risk factors for mortality in SAP patients. SAP patients with high creatinine and prolonged APTT upon admission require doctors to be vigilant. The main cause of death in SAP patients is pancreatitis-related organ failure and secondary infection.
目的比较重症急性胰腺炎(SAP)存活患者和非存活患者的临床特征,并探讨SAP患者的死亡风险。研究方法这是在重症急性胰腺炎诊治中心进行的一项单中心回顾性研究。根据结果,SAP 患者被分为存活组和非存活组。采用单因素方差分析或独立检验比较两组患者的临床特征。采用多变量回顾性分析确定 SAP 患者的死亡风险因素。结果研究共纳入486例SAP患者,SAP患者的90天死亡率为13.58%。SAP 的常见病因是胆道疾病(69.75%)和高脂血症(17.28%)。SAP 最常见的并发症是器官衰竭(55.14%)、ARDS(50.62%)、AKI(30.45%)、败血症(27.16%)和腹腔积液(27.57%)。非存活组和存活组在年龄、并发症和医疗干预方面存在差异。死亡的主要原因是感染(46.97%)、腹腔出血(28.79%)和器官衰竭(9.09%)。二元逻辑回归分析显示,非存活组和存活组在年龄、AKI、脓毒症、腹腔出血、器官衰竭、开腹手术、肌酐和 APTT 方面存在显著差异。结论年龄、AKI、脓毒症、腹腔出血和器官衰竭是SAP患者死亡的风险因素。入院时血肌酐较高且 APTT 延长的 SAP 患者需要医生提高警惕。SAP患者的主要死因是胰腺炎相关器官衰竭和继发性感染。
{"title":"Risk Factors for Death in Patients with Severe Acute Pancreatitis in Guizhou Province, China","authors":"Jun Li, Jingyan Gao, Min Huang, Xiaoyun Fu, Bao Fu","doi":"10.1155/2024/8236616","DOIUrl":"https://doi.org/10.1155/2024/8236616","url":null,"abstract":"<i>Aim</i>. To compare the clinical characteristics of survival and nonsurvival patients with severe acute pancreatitis (SAP) and explore the risk of mortality in SAP patients. <i>Methods</i>. This was a single-center retrospective study performed in a severe acute pancreatitis diagnosis and treatment center. According to the outcome, SAP patients were divided into survival group and nonsurvival group. One-way ANOVA or independent <span><svg height=\"8.02022pt\" style=\"vertical-align:-0.2063999pt\" version=\"1.1\" viewbox=\"-0.0498162 -7.81382 4.54925 8.02022\" width=\"4.54925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"></path></g></svg>-</span>test was used to compare the clinical characteristics of two groups of patients. Multivariate retrospective analysis was used to identify risk factors for mortality in SAP patients. <i>Results</i>. A total of 486 SAP patients were included in the study, and the 90-day mortality for SAP patients was 13.58%. The common etiologies of SAP are biliary tract diseases (69.75%) and hyperlipidemia (17.28%). The most common complications caused by SAP were organ failure (55.14%), ARDS (50.62%), AKI (30.45%), sepsis (27.16%), and abdominal fluid collection (27.57%). There were differences in age, complications, and medical intervention between the nonsurvival group and the survival group. The main causes of death were infection (46.97%), abdominal bleeding (28.79%), and organ failure (9.09%). The binary logistic regression analysis showed that there were significant differences in age, AKI, sepsis, abdominal hemorrhage, organ failure, laparotomy, creatinine, and APTT between the nonsurvival group and the survival group. <i>Conclusion</i>. Age, AKI, sepsis, abdominal hemorrhage, and organ failure are risk factors for mortality in SAP patients. SAP patients with high creatinine and prolonged APTT upon admission require doctors to be vigilant. The main cause of death in SAP patients is pancreatitis-related organ failure and secondary infection.","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"63 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140587367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Risk Scores for Predicting Adverse Outcomes in Acute Lower Gastrointestinal Bleeding 预测急性下消化道出血不良后果的风险评分比较
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-03-21 DOI: 10.1155/2024/3111414
Chenyang Li, Enqiang Linghu, Chao Chen
<i>Purpose</i>. Acute lower gastrointestinal bleeding (ALGIB) is a common emergency in gastroenterology. Currently, there is insufficient information to predict adverse outcomes in patients with acute lower gastrointestinal bleeding. Our study is aimed at comparing the effectiveness of the clinical risk scores currently utilized and their ability to predict significant outcomes in lower gastrointestinal bleeding. <i>Methods</i>. We conducted a retrospective observational study of patients who were admitted to ALGIB and underwent colonoscopy or angiography at a single center between January 2018 and December 2022. Adverse outcomes associated with ALGIB included rebleeding, blood transfusion, hemostatic interventions, and in-hospital death. We calculated six risk scores at admission (Oakland, Birmingham, SHA<sub>2</sub>PE, Ramaekers, SALGIB, and CNUH-5). We measured the accuracy of these scores using the area under the receiver operating characteristic curve (AUC) and compared them with DeLong’s test. <i>Results</i>. 123 patients with confirmed LGIB (aged 65 years, 55-75) were finally included. The most common diagnoses were colorectal cancer (25%) and hemorrhoids (14%). All scores demonstrated sufficient and comparable effectiveness for hemostatic intervention but no discrimination for rebleeding. The Oakland and SALGIB scores were superior to the other scores in predicting blood transfusion (AUC: 0.97 and 0.95, respectively; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"></path></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800000002 -8.34882 28.184 11.7782" width="28.184pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,22.605,0)"></path></g><g transform="matrix(.013,0,0,-0.013,28.845,0)"></path></g><g transform="matrix(.013,0,0,-0.013,31.809,0)"></path></g><g transform="matrix(.013,0,0,-0.013,38.049,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,44.289,0)"></path></g></svg>)</span></span> and any adverse outcomes (AUC: 0.78 and 0.78, respectively; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><use xlink:href="#g113-113"></use></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"><use xlink:href="#g117-34"></use></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800000002 -8.34882 28.184 11.7782" width="28.184pt" xmlns="http://www.w3.
目的。急性下消化道出血(ALGIB)是消化内科常见的急症。目前,预测急性下消化道出血患者不良后果的信息不足。我们的研究旨在比较目前使用的临床风险评分的有效性及其预测下消化道出血重大后果的能力。研究方法我们对 2018 年 1 月至 2022 年 12 月期间因 ALGIB 入院并在一个中心接受结肠镜检查或血管造影术的患者进行了一项回顾性观察研究。与ALGIB相关的不良后果包括再出血、输血、止血干预和院内死亡。我们计算了入院时的六个风险评分(奥克兰、伯明翰、SHA2PE、Ramaekers、SALGIB 和 CNUH-5)。我们用接收者操作特征曲线下面积(AUC)来衡量这些评分的准确性,并与 DeLong 检验进行比较。结果最终纳入了 123 名确诊为 LGIB 的患者(65 岁,55-75 岁)。最常见的诊断是结肠直肠癌(25%)和痔疮(14%)。所有评分均显示止血干预具有足够且可比的有效性,但对再出血没有区分。奥克兰和 SALGIB 评分在预测输血(AUC 分别为 0.97 和 0.95;)和任何不良后果(AUC 分别为 0.78 和 0.78;)方面优于其他评分。结论Oakland和SALGIB评分在预测ALGIB患者输血需求方面优于其他评分,但没有一种预测工具在所有结果方面具有最佳能力。为了更好地对 ALGIB 进行风险分层,需要性能更高的新型风险分层评分。
{"title":"Comparison of Risk Scores for Predicting Adverse Outcomes in Acute Lower Gastrointestinal Bleeding","authors":"Chenyang Li, Enqiang Linghu, Chao Chen","doi":"10.1155/2024/3111414","DOIUrl":"https://doi.org/10.1155/2024/3111414","url":null,"abstract":"&lt;i&gt;Purpose&lt;/i&gt;. Acute lower gastrointestinal bleeding (ALGIB) is a common emergency in gastroenterology. Currently, there is insufficient information to predict adverse outcomes in patients with acute lower gastrointestinal bleeding. Our study is aimed at comparing the effectiveness of the clinical risk scores currently utilized and their ability to predict significant outcomes in lower gastrointestinal bleeding. &lt;i&gt;Methods&lt;/i&gt;. We conducted a retrospective observational study of patients who were admitted to ALGIB and underwent colonoscopy or angiography at a single center between January 2018 and December 2022. Adverse outcomes associated with ALGIB included rebleeding, blood transfusion, hemostatic interventions, and in-hospital death. We calculated six risk scores at admission (Oakland, Birmingham, SHA&lt;sub&gt;2&lt;/sub&gt;PE, Ramaekers, SALGIB, and CNUH-5). We measured the accuracy of these scores using the area under the receiver operating characteristic curve (AUC) and compared them with DeLong’s test. &lt;i&gt;Results&lt;/i&gt;. 123 patients with confirmed LGIB (aged 65 years, 55-75) were finally included. The most common diagnoses were colorectal cancer (25%) and hemorrhoids (14%). All scores demonstrated sufficient and comparable effectiveness for hemostatic intervention but no discrimination for rebleeding. The Oakland and SALGIB scores were superior to the other scores in predicting blood transfusion (AUC: 0.97 and 0.95, respectively; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800000002 -8.34882 28.184 11.7782\" width=\"28.184pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,22.605,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,28.845,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,31.809,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,38.049,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,44.289,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;)&lt;/span&gt;&lt;/span&gt; and any adverse outcomes (AUC: 0.78 and 0.78, respectively; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;use xlink:href=\"#g113-113\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;use xlink:href=\"#g117-34\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800000002 -8.34882 28.184 11.7782\" width=\"28.184pt\" xmlns=\"http://www.w3.","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"3 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140198779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid Metabolism-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Advanced Gastric Cancer 与脂质代谢相关的基因特征可预测晚期胃癌的预后并指示免疫微环境渗透
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-02-26 DOI: 10.1155/2024/6639205
Lijian He, Qiange Ye, Yanmei Zhu, Wenqi Zhong, Guifang Xu, Lei Wang, Zhangding Wang, Xiaoping Zou
Objective. Abnormal lipid metabolism is known to influence the malignant behavior of gastric cancer. However, the underlying mechanism remains elusive. In this study, we comprehensively analyzed the biological significance of genes involved in lipid metabolism in advanced gastric cancer (AGC). Methods. We obtained gene expression profiles from The Cancer Genome Atlas (TCGA) database for early and advanced gastric cancer samples and performed differential expression analysis to identify specific lipid metabolism-related genes in AGC. We then used consensus cluster analysis to classify AGC patients into molecular subtypes based on lipid metabolism and constructed a diagnostic model using least absolute shrinkage and selection operator- (LASSO-) Cox regression analysis and Gene Set Enrichment Analysis (GSEA). We evaluated the discriminative ability and clinical significance of the model using the Kaplan-Meier (KM) curve, ROC curve, DCA curve, and nomogram. We also estimated immune levels based on immune microenvironment expression, immune checkpoints, and immune cell infiltration and obtained hub genes by weighted gene co-expression network analysis (WGCNA) of differential genes from the two molecular subtypes. Results. We identified 6 lipid metabolism genes that were associated with the prognosis of AGC and used consistent clustering to classify AGC patients into two subgroups with significantly different overall survival and immune microenvironment. Our risk model successfully classified patients in the training and validation sets into high-risk and low-risk groups. The high-risk score predicted poor prognosis and indicated low degree of immune infiltration. Subgroup analysis showed that the risk model was an independent predictor of prognosis in AGC. Furthermore, our results indicated that most chemotherapeutic agents are more effective for AGC patients in the low-risk group than in the high-risk group, and risk scores for AGC are strongly correlated with drug sensitivity. Finally, we performed qRT-PCR experiments to verify the relevant results. Conclusion. Our findings suggest that lipid metabolism-related genes play an important role in predicting the prognosis of AGC and regulating immune invasion. These results have important implications for the development of targeted therapies for AGC patients.
目的。众所周知,脂质代谢异常会影响胃癌的恶性行为。然而,其内在机制仍不明确。本研究全面分析了晚期胃癌(AGC)中脂质代谢相关基因的生物学意义。研究方法我们从癌症基因组图谱(TCGA)数据库中获取了早期和晚期胃癌样本的基因表达谱,并进行了差异表达分析,以确定 AGC 中特定的脂质代谢相关基因。然后,我们使用共识聚类分析将 AGC 患者分为基于脂质代谢的分子亚型,并使用最小绝对收缩和选择算子(LASSO)Cox 回归分析和基因组富集分析(Gene Set Enrichment Analysis,GSEA)构建了诊断模型。我们使用 Kaplan-Meier (KM) 曲线、ROC 曲线、DCA 曲线和提名图评估了模型的鉴别能力和临床意义。我们还根据免疫微环境表达、免疫检查点和免疫细胞浸润估计了免疫水平,并通过对两种分子亚型的差异基因进行加权基因共表达网络分析(WGCNA)获得了枢纽基因。结果我们发现了6个与AGC预后相关的脂质代谢基因,并利用一致聚类将AGC患者分为两个亚组,这两个亚组的总生存期和免疫微环境存在显著差异。我们的风险模型成功地将训练集和验证集中的患者分为高风险组和低风险组。高风险评分预示着不良预后,并表明免疫浸润程度较低。亚组分析表明,风险模型是预测 AGC 预后的独立指标。此外,我们的研究结果表明,大多数化疗药物对低风险组的 AGC 患者比对高风险组的患者更有效,而且 AGC 的风险评分与药物敏感性密切相关。最后,我们进行了 qRT-PCR 实验来验证相关结果。结论我们的研究结果表明,脂质代谢相关基因在预测 AGC 的预后和调控免疫侵袭方面发挥着重要作用。这些结果对开发针对 AGC 患者的靶向疗法具有重要意义。
{"title":"Lipid Metabolism-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Advanced Gastric Cancer","authors":"Lijian He, Qiange Ye, Yanmei Zhu, Wenqi Zhong, Guifang Xu, Lei Wang, Zhangding Wang, Xiaoping Zou","doi":"10.1155/2024/6639205","DOIUrl":"https://doi.org/10.1155/2024/6639205","url":null,"abstract":"<i>Objective</i>. Abnormal lipid metabolism is known to influence the malignant behavior of gastric cancer. However, the underlying mechanism remains elusive. In this study, we comprehensively analyzed the biological significance of genes involved in lipid metabolism in advanced gastric cancer (AGC). <i>Methods</i>. We obtained gene expression profiles from The Cancer Genome Atlas (TCGA) database for early and advanced gastric cancer samples and performed differential expression analysis to identify specific lipid metabolism-related genes in AGC. We then used consensus cluster analysis to classify AGC patients into molecular subtypes based on lipid metabolism and constructed a diagnostic model using least absolute shrinkage and selection operator- (LASSO-) Cox regression analysis and Gene Set Enrichment Analysis (GSEA). We evaluated the discriminative ability and clinical significance of the model using the Kaplan-Meier (KM) curve, ROC curve, DCA curve, and nomogram. We also estimated immune levels based on immune microenvironment expression, immune checkpoints, and immune cell infiltration and obtained hub genes by weighted gene co-expression network analysis (WGCNA) of differential genes from the two molecular subtypes. <i>Results</i>. We identified 6 lipid metabolism genes that were associated with the prognosis of AGC and used consistent clustering to classify AGC patients into two subgroups with significantly different overall survival and immune microenvironment. Our risk model successfully classified patients in the training and validation sets into high-risk and low-risk groups. The high-risk score predicted poor prognosis and indicated low degree of immune infiltration. Subgroup analysis showed that the risk model was an independent predictor of prognosis in AGC. Furthermore, our results indicated that most chemotherapeutic agents are more effective for AGC patients in the low-risk group than in the high-risk group, and risk scores for AGC are strongly correlated with drug sensitivity. Finally, we performed qRT-PCR experiments to verify the relevant results. <i>Conclusion</i>. Our findings suggest that lipid metabolism-related genes play an important role in predicting the prognosis of AGC and regulating immune invasion. These results have important implications for the development of targeted therapies for AGC patients.","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"31 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139968392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Nursing Value Analysis and Risk Assessment of Acute Gastrointestinal Bleeding Using Multiagent Reinforcement Learning Algorithm 撤回:利用多代理强化学习算法对急性消化道出血进行护理价值分析和风险评估
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-20 DOI: 10.1155/2023/9818274
Gastroenterology Research and Practice
{"title":"Retracted: Nursing Value Analysis and Risk Assessment of Acute Gastrointestinal Bleeding Using Multiagent Reinforcement Learning Algorithm","authors":"Gastroenterology Research and Practice","doi":"10.1155/2023/9818274","DOIUrl":"https://doi.org/10.1155/2023/9818274","url":null,"abstract":"<jats:p />","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"18 7","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138954992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Gut Microbiota Variations between Henoch-Schonlein Purpura and Henoch-Schonlein Purpura Nephritis. 撤回:紫癜性肾炎与紫癜性肾炎之间的肠道微生物群变异。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-20 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9840245
Gastroenterology Research And Practice

[This retracts the article DOI: 10.1155/2022/4003491.].

[此文撤稿,DOI: 10.1155/2022/4003491.]。
{"title":"Retracted: Gut Microbiota Variations between Henoch-Schonlein Purpura and Henoch-Schonlein Purpura Nephritis.","authors":"Gastroenterology Research And Practice","doi":"10.1155/2023/9840245","DOIUrl":"10.1155/2023/9840245","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/4003491.].</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"9840245"},"PeriodicalIF":2.0,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10752684/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139048626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study 肠内吸附剂 Silicol®gel 对肠易激综合征亚型 IBS-D 或混合型成人的疗效:观察性开放标签研究
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-16 DOI: 10.1155/2023/3432763
Gordon Crawford, Rory Taylor, David Young, Chris G. Hatton
<i>Background</i>. Irritable bowel syndrome (IBS) is a common chronic gut-brain interaction disorder with limited effective treatment options. Intestinal adsorbents have a high adsorption capacity for gut irritants and may provide nonpharmacological alternatives. <i>Objectives</i>. This post marketing study is aimed at providing up-to-date evidence to support the safety and efficacy in normal use of an established medical device for IBS treatment. <i>Methods</i>. In this open-label, observational study, adults with IBS with predominant diarrhoea (IBS-D) or IBS with mixed bowel habits (IBS-M), according to Rome IV criteria, received 4 weeks of treatment with the enteroadsorbent Silicol®gel, a CE-certified, licenced, medical device containing colloidal silicic acid. Eligible participants were assessed at baseline (visit 1; in-clinic) and after 1 (visit 2; telephone), 2 (visit 3; telephone), and 4 (visit 4; in-clinic) weeks of treatment. The primary endpoint was the proportion of participants with an overall reduction in the IBS severity scoring system <span><svg height="11.5564pt" style="vertical-align:-2.26807pt" version="1.1" viewbox="-0.0498162 -9.28833 59.297 11.5564" width="59.297pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g><g transform="matrix(.013,0,0,-0.013,4.498,0)"></path></g><g transform="matrix(.013,0,0,-0.013,8.931,0)"></path></g><g transform="matrix(.013,0,0,-0.013,16.575,0)"></path></g><g transform="matrix(.013,0,0,-0.013,24.981,0)"><use xlink:href="#g190-84"></use></g><g transform="matrix(.013,0,0,-0.013,31.143,0)"><use xlink:href="#g190-84"></use></g><g transform="matrix(.013,0,0,-0.013,37.305,0)"><use xlink:href="#g190-84"></use></g><g transform="matrix(.013,0,0,-0.013,43.536,0)"></path></g><g transform="matrix(.013,0,0,-0.013,51.666,0)"></path></g></svg><span></span><span><svg height="11.5564pt" style="vertical-align:-2.26807pt" version="1.1" viewbox="62.8791838 -9.28833 12.689 11.5564" width="12.689pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,62.929,0)"></path></g><g transform="matrix(.013,0,0,-0.013,69.169,0)"></path></g></svg>,</span></span> representing clinically meaningful improvement. Key secondary endpoints were a reduction in common IBS symptoms and improved quality of life (QoL). <i>Results</i>. Among the 67 treated participants (IBS-D: 37; IBS-M: 30), 65 completed the study. At visit 4, 83.6% (56/67) of participants achieved a reduction in IBS <span><svg height="9.39034pt" style="vertical-align:-0.6370001pt" version="1.1" viewbox="-0.0498162 -8.75334 29.818 9.39034" width="29.818pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><use xlink:href="#g190-84"></use></g><g transform="matrix(.013,0,0,-0.013,6.162,0)"><use xlink:href="#g190-84"></use></g><g transform="matrix(.013,0,0,-0.013,
背景:肠易激综合征(IBS肠易激综合征(IBS)是一种常见的慢性肠脑交互障碍,有效的治疗方法有限。肠道吸附剂对肠道刺激物有很强的吸附能力,可提供非药物治疗方法。研究目的这项上市后研究旨在提供最新证据,以支持正常使用一种成熟的医疗设备治疗肠易激综合征的安全性和有效性。研究方法在这项开放标签的观察性研究中,根据罗马IV标准,患有以腹泻为主的肠易激综合征(IBS-D)或混合排便习惯的肠易激综合征(IBS-M)的成人接受了为期4周的肠道吸附剂 Silicol®gel 治疗。符合条件的参与者在基线(第 1 次就诊;诊所内)和治疗 1 周(第 2 次就诊;电话)、2 周(第 3 次就诊;电话)和 4 周(第 4 次就诊;诊所内)后接受评估。主要终点是肠易激综合征严重程度评分系统总体下降的参与者比例,这代表了有临床意义的改善。主要次要终点是常见肠易激综合征症状的减轻和生活质量(QoL)的提高。研究结果在接受治疗的 67 名参与者中(IBS-D:37 人;IBS-M:30 人),65 人完成了研究。在第 4 次就诊时,83.6% 的参与者(56/67)的肠易激综合征症状有所减轻。第 1 次就诊时,IBS SSS 平均值(标准差 [SD])为 323.4 (55.7),第 4 次就诊时为 160.3 (90.3)(总体变化:-163.1 (101.7);95% 置信区间 [CI] 138.3,187.9,)。与第 1 次就诊时相比,第 4 次就诊时所有主要肠易激综合征症状的严重程度均明显减轻,生活质量总体改善(),第 1 次和第 2 次就诊时的情况也有所改善。研究结论在这项对患有肠易激综合征(IBS-D)和肠易激综合征(IBS-M)的患者进行的开放标签研究中,Silicol®凝胶对肠易激综合征症状有明显的临床改善,证明肠吸收剂可能对这类人群有临床益处。
{"title":"Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study","authors":"Gordon Crawford, Rory Taylor, David Young, Chris G. Hatton","doi":"10.1155/2023/3432763","DOIUrl":"https://doi.org/10.1155/2023/3432763","url":null,"abstract":"&lt;i&gt;Background&lt;/i&gt;. Irritable bowel syndrome (IBS) is a common chronic gut-brain interaction disorder with limited effective treatment options. Intestinal adsorbents have a high adsorption capacity for gut irritants and may provide nonpharmacological alternatives. &lt;i&gt;Objectives&lt;/i&gt;. This post marketing study is aimed at providing up-to-date evidence to support the safety and efficacy in normal use of an established medical device for IBS treatment. &lt;i&gt;Methods&lt;/i&gt;. In this open-label, observational study, adults with IBS with predominant diarrhoea (IBS-D) or IBS with mixed bowel habits (IBS-M), according to Rome IV criteria, received 4 weeks of treatment with the enteroadsorbent Silicol®gel, a CE-certified, licenced, medical device containing colloidal silicic acid. Eligible participants were assessed at baseline (visit 1; in-clinic) and after 1 (visit 2; telephone), 2 (visit 3; telephone), and 4 (visit 4; in-clinic) weeks of treatment. The primary endpoint was the proportion of participants with an overall reduction in the IBS severity scoring system &lt;span&gt;&lt;svg height=\"11.5564pt\" style=\"vertical-align:-2.26807pt\" version=\"1.1\" viewbox=\"-0.0498162 -9.28833 59.297 11.5564\" width=\"59.297pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,4.498,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,8.931,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,16.575,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,24.981,0)\"&gt;&lt;use xlink:href=\"#g190-84\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,31.143,0)\"&gt;&lt;use xlink:href=\"#g190-84\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,37.305,0)\"&gt;&lt;use xlink:href=\"#g190-84\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,43.536,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,51.666,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.5564pt\" style=\"vertical-align:-2.26807pt\" version=\"1.1\" viewbox=\"62.8791838 -9.28833 12.689 11.5564\" width=\"12.689pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,62.929,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,69.169,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;,&lt;/span&gt;&lt;/span&gt; representing clinically meaningful improvement. Key secondary endpoints were a reduction in common IBS symptoms and improved quality of life (QoL). &lt;i&gt;Results&lt;/i&gt;. Among the 67 treated participants (IBS-D: 37; IBS-M: 30), 65 completed the study. At visit 4, 83.6% (56/67) of participants achieved a reduction in IBS &lt;span&gt;&lt;svg height=\"9.39034pt\" style=\"vertical-align:-0.6370001pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.75334 29.818 9.39034\" width=\"29.818pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;use xlink:href=\"#g190-84\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,6.162,0)\"&gt;&lt;use xlink:href=\"#g190-84\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"19 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138684245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Diagnostic Accuracy of a Fecal Immunochemical Test in Detecting Colorectal Cancer and Advanced Precancerous Colorectal Neoplasia in Patients with Iron Deficiency: A Protocol for Systematic Review and Meta-Analysis 粪便免疫化学检验在检测缺铁患者结直肠癌和晚期结直肠癌前病变方面的诊断准确性:系统回顾与元分析方案
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-08 DOI: 10.1155/2023/5982580
Jennifer Pham, Geraldine Laven-Law, Jean M. Winter, Molla M. Wassie, Charles Cock, Erin L. Symonds
Background. Iron deficiency (ID) is a common micronutrient deficiency and the leading cause of anemia worldwide. ID can be caused by chronic occult blood loss from colorectal neoplasia including colorectal cancer (CRC) and advanced precancerous colorectal lesions. Current guidelines recommend colonoscopy in both men and postmenopausal women presenting with ID anemia (IDA). However, there is controversy on the investigation of patients presenting with a lower risk of CRC including younger women with ID and those with nonanemic ID (NAID). There is a need for a triaging tool to identify which ID patients may benefit from colonoscopy. The fecal immunochemical test (FIT) is sensitive for CRC screening in an asymptomatic population, but its role in ID patients is unclear. The aim of this study is to conduct a systematic review to determine the diagnostic accuracy of FIT for detecting CRC and advanced precancerous neoplasia in individuals presenting with ID with or without anemia. Methods and Analysis. This protocol conforms with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols and Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. A comprehensive search of the MEDLINE, Embase, and Web of Science databases will be undertaken for studies published after 2010 which involve patients with ID, who completed a FIT in the 6 months prior to colonoscopy, with FIT sensitivity and specificity calculated against the reference standard colonoscopy. The search will be limited to studies conducted after 2010 to reduce variability in colonoscopy quality. Risk of bias assessment will be conducted using the Quality Assessment of Diagnostic Accuracy Studies version 2. FIT sensitivity and specificity will be the primary measure of diagnostic accuracy, and data will be analysed using a random effects meta-analysis. Discussion. This review and meta-analysis will be the first to systematically explore the value of the FIT as a triaging tool for patients with ID. This trial is registered with CRD42022367162.
背景。缺铁(ID)是一种常见的微量营养素缺乏症,也是全球贫血的主要原因。IDA可由结肠直肠肿瘤(包括结肠直肠癌(CRC)和晚期结肠直肠癌前病变)导致的慢性隐性失血引起。目前的指南建议男性和绝经后女性在出现 ID 贫血(IDA)时进行结肠镜检查。然而,对 CRC 风险较低的患者(包括较年轻的 ID 女性患者和非贫血 ID 患者 (NAID))的检查还存在争议。我们需要一种分流工具来确定哪些 ID 患者可能受益于结肠镜检查。粪便免疫化学检验(FIT)对无症状人群的 CRC 筛查很敏感,但它在 ID 患者中的作用尚不明确。本研究旨在进行一项系统性回顾,以确定 FIT 在检测伴有或不伴有贫血的 ID 患者的 CRC 和晚期癌前病变方面的诊断准确性。方法与分析。本方案符合《系统综述和荟萃分析方案首选报告项目》(Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols)和《诊断测试准确性系统综述科克伦手册》(Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy)。我们将全面检索 MEDLINE、Embase 和 Web of Science 数据库中 2010 年以后发表的涉及 ID 患者的研究,这些患者在结肠镜检查前 6 个月内完成了 FIT,并对照参考标准结肠镜检查计算了 FIT 的敏感性和特异性。搜索仅限于 2010 年之后进行的研究,以减少结肠镜检查质量的变化。偏倚风险评估将采用诊断准确性研究质量评估第 2 版进行。FIT 敏感性和特异性将作为诊断准确性的主要衡量标准,数据将采用随机效应荟萃分析法进行分析。讨论。该综述和荟萃分析将首次系统地探讨FIT作为ID患者分诊工具的价值。该试验的注册号为 CRD42022367162。
{"title":"The Diagnostic Accuracy of a Fecal Immunochemical Test in Detecting Colorectal Cancer and Advanced Precancerous Colorectal Neoplasia in Patients with Iron Deficiency: A Protocol for Systematic Review and Meta-Analysis","authors":"Jennifer Pham, Geraldine Laven-Law, Jean M. Winter, Molla M. Wassie, Charles Cock, Erin L. Symonds","doi":"10.1155/2023/5982580","DOIUrl":"https://doi.org/10.1155/2023/5982580","url":null,"abstract":"<i>Background</i>. Iron deficiency (ID) is a common micronutrient deficiency and the leading cause of anemia worldwide. ID can be caused by chronic occult blood loss from colorectal neoplasia including colorectal cancer (CRC) and advanced precancerous colorectal lesions. Current guidelines recommend colonoscopy in both men and postmenopausal women presenting with ID anemia (IDA). However, there is controversy on the investigation of patients presenting with a lower risk of CRC including younger women with ID and those with nonanemic ID (NAID). There is a need for a triaging tool to identify which ID patients may benefit from colonoscopy. The fecal immunochemical test (FIT) is sensitive for CRC screening in an asymptomatic population, but its role in ID patients is unclear. The aim of this study is to conduct a systematic review to determine the diagnostic accuracy of FIT for detecting CRC and advanced precancerous neoplasia in individuals presenting with ID with or without anemia. <i>Methods and Analysis</i>. This protocol conforms with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols and <i>Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy</i>. A comprehensive search of the MEDLINE, Embase, and Web of Science databases will be undertaken for studies published after 2010 which involve patients with ID, who completed a FIT in the 6 months prior to colonoscopy, with FIT sensitivity and specificity calculated against the reference standard colonoscopy. The search will be limited to studies conducted after 2010 to reduce variability in colonoscopy quality. Risk of bias assessment will be conducted using the Quality Assessment of Diagnostic Accuracy Studies version 2. FIT sensitivity and specificity will be the primary measure of diagnostic accuracy, and data will be analysed using a random effects meta-analysis. <i>Discussion</i>. This review and meta-analysis will be the first to systematically explore the value of the FIT as a triaging tool for patients with ID. This trial is registered with CRD42022367162.","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"8 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138555867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonic Endoscopic Tubing Is Safe and Effective Approach for Washed Microbiota Transplantation in Autistic Children. 结肠内镜管是自闭症儿童洗净菌群移植安全有效的方法。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-11-22 eCollection Date: 2023-01-01 DOI: 10.1155/2023/7838601
Qing-Fen Yuan, Hui-Yi Wu, Xian-Yun Chen, Ya-Mei Zheng, Song-Lin Fu, Xing-He Wang, Jian-Wei Zhu, Jian-Dong Guo, Xing-Xiang He, Li-Hao Wu

Background: Washed microbiota transplantation (WMT) as the improved methods of fecal microbiota transplantation has been employed as a therapeutic approach for ameliorating symptoms associated with autism spectrum disorder (ASD). In this context, colonic transendoscopic enteral tubing (TET) has been utilized as a novel procedure for administering WMT.

Methods: Data of children with ASD who received WMT by TET were retrospectively reviewed, including bowel preparation methods, TET operation time, success rate, tube retention time, the comfort of children, adverse events, and parent satisfaction.

Results: A total of 38 participants underwent 124 colonic TET catheterization procedures. The average time of TET operation was 15 minutes, and the success rate was 100% (124/124). There was no significant difference in TET operation time between high-seniority physicians and low-seniority physicians. In 123 procedures (99%), the TET tube allowed the completion of WMT treatment for 6 consecutive days. In 118 procedures (95.2%), the tube was detached spontaneously after the end of the treatment course, and the average TET tube retention time was 8 days. There was no incidence of tube blockage during the treatment course. No severe adverse events occurred during follow-up. Parents of all participants reported a high level of satisfaction with TET.

Conclusion: Colonic TET is a safe and feasible method for WMT in children with ASD.

背景:洗涤微生物群移植(WMT)作为粪便微生物群移植的改进方法,已被用作改善自闭症谱系障碍(ASD)相关症状的治疗方法。在这种情况下,结肠经内窥镜肠内插管(TET)已被用作一种给药WMT的新方法。方法:回顾性分析经TET治疗的ASD患儿行WMT的资料,包括肠道准备方法、TET手术时间、成功率、留管时间、患儿舒适度、不良事件、家长满意度等。结果:共有38名参与者接受了124次结肠TET导管术。TET手术平均时间15分钟,成功率100%(124/124)。高年资医师与低年资医师在TET手术时间上无显著差异。在123例(99%)手术中,TET管允许连续6天完成WMT治疗。118例(95.2%)患者在疗程结束后自动脱管,平均留管时间为8天。治疗过程中均未发生输卵管堵塞。随访期间未发生严重不良事件。所有参与者的家长对TET的满意度都很高。结论:结肠TET治疗ASD患儿WMT是一种安全可行的方法。
{"title":"Colonic Endoscopic Tubing Is Safe and Effective Approach for Washed Microbiota Transplantation in Autistic Children.","authors":"Qing-Fen Yuan, Hui-Yi Wu, Xian-Yun Chen, Ya-Mei Zheng, Song-Lin Fu, Xing-He Wang, Jian-Wei Zhu, Jian-Dong Guo, Xing-Xiang He, Li-Hao Wu","doi":"10.1155/2023/7838601","DOIUrl":"10.1155/2023/7838601","url":null,"abstract":"<p><strong>Background: </strong>Washed microbiota transplantation (WMT) as the improved methods of fecal microbiota transplantation has been employed as a therapeutic approach for ameliorating symptoms associated with autism spectrum disorder (ASD). In this context, colonic transendoscopic enteral tubing (TET) has been utilized as a novel procedure for administering WMT.</p><p><strong>Methods: </strong>Data of children with ASD who received WMT by TET were retrospectively reviewed, including bowel preparation methods, TET operation time, success rate, tube retention time, the comfort of children, adverse events, and parent satisfaction.</p><p><strong>Results: </strong>A total of 38 participants underwent 124 colonic TET catheterization procedures. The average time of TET operation was 15 minutes, and the success rate was 100% (124/124). There was no significant difference in TET operation time between high-seniority physicians and low-seniority physicians. In 123 procedures (99%), the TET tube allowed the completion of WMT treatment for 6 consecutive days. In 118 procedures (95.2%), the tube was detached spontaneously after the end of the treatment course, and the average TET tube retention time was 8 days. There was no incidence of tube blockage during the treatment course. No severe adverse events occurred during follow-up. Parents of all participants reported a high level of satisfaction with TET.</p><p><strong>Conclusion: </strong>Colonic TET is a safe and feasible method for WMT in children with ASD.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"7838601"},"PeriodicalIF":2.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138459291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of Early Enteral Feeding with a Locally Prepared Protein-Energy Ration after Surgery for Acute Generalised Peritonitis: A Randomised Trial in Two Hospitals in Bukavu, Eastern Democratic Republic of Congo. 在刚果民主共和国东部布卡武的两家医院进行的一项随机试验:急性全局性腹膜炎术后早期肠内喂养当地制备的蛋白质-能量日粮的益处
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-11-17 eCollection Date: 2023-01-01 DOI: 10.1155/2023/1764242
Jean Paul Buhendwa Cikwanine, Jonathan Tunangoya Yoyu, Désiré Munyali Alumeti, Bernard Mugisho, John Mutendela Kivukuto, Rivain Fefe Iteke, Ona Longombe Ahuka, Willy Kalau Arung

Background: Acute generalised peritonitis (AGP) is a common and serious digestive surgery pathology. Undernutrition exacerbates patient condition and compromises their postoperative prognosis. Early enteral nutrition is recommended to reduce postoperative complications, but its availability and cost are problematic in low-income countries. The objective of this study was to evaluate the impact of providing early enteral feeding (EEF) to postoperative patients with intestinal perforation AGP using a locally prepared protein-energy food ration in two hospitals in Bukavu, a city of South Kivu, in the eastern part of the Democratic Republic of Congo.

Methods: A prospective, randomised controlled trial with two groups of patients was conducted to investigate the effects of EEF with a local mixture versus enteral feeding after peristalsis had returned (control group) in patients who underwent laparotomy for AGP caused by ileal perforation. The local mixture consisted of soybean, maize, white rice, and pineapple. The trial included 66 patients with ileal perforation peritonitis.

Results: The results comparing early enteral fed and nonfed patients showed significant differences in peristalsis recovery time (2.1 (0.6) days vs. 3.8 (1.2) days, p < 0.0001) and length of hospital stay (25.5 (14.9) days vs. 39.4 (25.3) days, p = 0.0046). Bivariate analyses indicated a significant early enteral feeding (EEF) reduced of 9.1% (vs. 36.4%, p = 0.0082) in parietal infections and 3.4% (28.1%, p = 0.009) in fistulas (p = 0.009) when EEF was included. In addition, EEF significantly reduced reintervention rates by 9.1% (p = 0.0003) and eliminated evisceration rates. EEF was also shown to reduce the incidence of malnutrition by 63.6% (p < 0.0001). Multivariate analysis showed that enteral nutrition significantly reduced the time to recovery of peristalsis (p = 0.0278) with an ORa of 0.3 and a 95% CI of 0.1-0.9. Moreover, EEF reduced malnutrition (p = 0.0039) with an ORa of 0.1 and a 95% CI of 0-0.4.

Conclusion: EEF with locally sourced protein-energy rations can enhance a patient's nutritional status and facilitate postoperative recovery. This procedure is advantageous and involved early enteral nutrition using locally manufactured rations, especially for those operated on for acute generalised peritonitis in the Democratic Republic of Congo.

背景:急性全身性腹膜炎(AGP)是一种常见而严重的消化外科病理。营养不良使患者病情恶化,影响其术后预后。建议早期肠内营养以减少术后并发症,但其可得性和成本在低收入国家存在问题。本研究的目的是评估在刚果民主共和国东部南基伍省布卡武市的两家医院,使用当地制备的蛋白质能量口粮为肠穿孔AGP术后患者提供早期肠内喂养(EEF)的影响。方法:采用前瞻性、随机对照试验,研究两组患者在回肠穿孔引起的AGP开腹手术后,局部混合EEF与肠内喂养的效果(对照组)。当地的混合物包括大豆、玉米、白米和菠萝。该试验包括66例回肠穿孔性腹膜炎患者。结果:早期肠内喂养与非肠内喂养患者在肠蠕动恢复时间(2.1(0.6)天比3.8(1.2)天,p < 0.0001)和住院时间(25.5(14.9)天比39.4(25.3)天,p = 0.0046)上存在显著差异。双变量分析显示,早期肠内喂养(EEF)显著减少了9.1% (36.4%,p = 0.0082)的壁感染和3.4% (28.1%,p = 0.009)的瘘管(p = 0.009)。此外,EEF显著降低了9.1%的再干预率(p = 0.0003),消除了内脏取出率。EEF还能将营养不良发生率降低63.6% (p < 0.0001)。多因素分析显示,肠内营养显著缩短了肠蠕动恢复时间(p = 0.0278), ORa为0.3,95% CI为0.1 ~ 0.9。此外,EEF减少营养不良(p = 0.0039), ORa为0.1,95% CI为0-0.4。结论:EEF与当地来源的蛋白质能量口粮可以改善患者的营养状况,促进术后恢复。该程序是有利的,涉及使用当地生产的口粮进行早期肠内营养,特别是对刚果民主共和国因急性全身性腹膜炎而进行手术的患者。
{"title":"Benefits of Early Enteral Feeding with a Locally Prepared Protein-Energy Ration after Surgery for Acute Generalised Peritonitis: A Randomised Trial in Two Hospitals in Bukavu, Eastern Democratic Republic of Congo.","authors":"Jean Paul Buhendwa Cikwanine, Jonathan Tunangoya Yoyu, Désiré Munyali Alumeti, Bernard Mugisho, John Mutendela Kivukuto, Rivain Fefe Iteke, Ona Longombe Ahuka, Willy Kalau Arung","doi":"10.1155/2023/1764242","DOIUrl":"https://doi.org/10.1155/2023/1764242","url":null,"abstract":"<p><strong>Background: </strong>Acute generalised peritonitis (AGP) is a common and serious digestive surgery pathology. Undernutrition exacerbates patient condition and compromises their postoperative prognosis. Early enteral nutrition is recommended to reduce postoperative complications, but its availability and cost are problematic in low-income countries. The objective of this study was to evaluate the impact of providing early enteral feeding (EEF) to postoperative patients with intestinal perforation AGP using a locally prepared protein-energy food ration in two hospitals in Bukavu, a city of South Kivu, in the eastern part of the Democratic Republic of Congo.</p><p><strong>Methods: </strong>A prospective, randomised controlled trial with two groups of patients was conducted to investigate the effects of EEF with a local mixture versus enteral feeding after peristalsis had returned (control group) in patients who underwent laparotomy for AGP caused by ileal perforation. The local mixture consisted of soybean, maize, white rice, and pineapple. The trial included 66 patients with ileal perforation peritonitis.</p><p><strong>Results: </strong>The results comparing early enteral fed and nonfed patients showed significant differences in peristalsis recovery time (2.1 (0.6) days vs. 3.8 (1.2) days, <i>p</i> < 0.0001) and length of hospital stay (25.5 (14.9) days vs. 39.4 (25.3) days, <i>p</i> = 0.0046). Bivariate analyses indicated a significant early enteral feeding (EEF) reduced of 9.1% (vs. 36.4%, <i>p</i> = 0.0082) in parietal infections and 3.4% (28.1%, <i>p</i> = 0.009) in fistulas (<i>p</i> = 0.009) when EEF was included. In addition, EEF significantly reduced reintervention rates by 9.1% (<i>p</i> = 0.0003) and eliminated evisceration rates. EEF was also shown to reduce the incidence of malnutrition by 63.6% (<i>p</i> < 0.0001). Multivariate analysis showed that enteral nutrition significantly reduced the time to recovery of peristalsis (<i>p</i> = 0.0278) with an ORa of 0.3 and a 95% CI of 0.1-0.9. Moreover, EEF reduced malnutrition (<i>p</i> = 0.0039) with an ORa of 0.1 and a 95% CI of 0-0.4.</p><p><strong>Conclusion: </strong>EEF with locally sourced protein-energy rations can enhance a patient's nutritional status and facilitate postoperative recovery. This procedure is advantageous and involved early enteral nutrition using locally manufactured rations, especially for those operated on for acute generalised peritonitis in the Democratic Republic of Congo.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"1764242"},"PeriodicalIF":2.0,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138459290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1